| 000 | 01458 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511214714.0 | ||
| 264 | 0 | _c19910110 | |
| 008 | 199101s 0 0 eng d | ||
| 022 | _a0007-1250 | ||
| 024 | 7 |
_a10.1192/bjp.157.3.327 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBowen, D M | |
| 245 | 0 | 0 |
_aTreatment of Alzheimer's disease. Molecular pathology versus neurotransmitter-based therapy. _h[electronic resource] |
| 260 |
_bThe British journal of psychiatry : the journal of mental science _cSep 1990 |
||
| 300 |
_a327-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlzheimer Disease _xgenetics |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xgenetics |
| 650 | 0 | 4 | _aAmyloid beta-Protein Precursor |
| 650 | 0 | 4 |
_aCerebral Cortex _xpathology |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 21 |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 |
_aCycloserine _xadministration & dosage |
| 650 | 0 | 4 |
_aGlutamates _xmetabolism |
| 650 | 0 | 4 | _aGlutamic Acid |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xmetabolism |
| 650 | 0 | 4 | _aProtease Inhibitors |
| 650 | 0 | 4 |
_aProtein Precursors _xgenetics |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xdrug effects |
| 773 | 0 |
_tThe British journal of psychiatry : the journal of mental science _gvol. 157 _gp. 327-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1192/bjp.157.3.327 _zAvailable from publisher's website |
| 999 |
_c1984970 _d1984970 |
||